RMIT University
Browse

Increased cortical surface area but not altered cortical thickness or gyrification in bipolar disorder following stabilisation from a first episode of mania

journal contribution
posted on 2024-11-03, 10:51 authored by Tamsyn Van Rheenen, Sue Cotton, Orwa Dandash, Karen HallamKaren Hallam
Background: Despite reports of altered brain morphology in established bipolar disorder (BD), there is limited understanding of when these morphological abnormalities emerge. Assessment of patients during the early course of illness can help to address this gap, but few studies have examined surface-based brain morphology in patients at this illness stage. Methods: We completed a secondary analysis of baseline data from a randomised control trial of BD individuals stabilised after their first episode of mania (FEM). The magnetic resonance imaging scans of n = 35 FEM patients and n = 29 age-matched healthy controls were analysed. Group differences in cortical thickness, surface area and gyrification were assessed at each vertex of the cortical surface using general linear models. Significant results were identified at p < 0.05 using cluster-wise correction. Results: The FEM group did not differ from healthy controls with regards to cortical thickness or gyrification. However, there were two clusters of increased surface area in the left hemisphere of FEM patients, with peak coordinates falling within the lateral occipital cortex and pars triangularis. Conclusions: Cortical thickness and gyrification appear to be intact in the aftermath of a first manic episode, whilst cortical surface area in the inferior/middle prefrontal and occipitoparietal cortex is increased compared to age-matched controls. It is possible that increased surface area in the FEM group is the outcome of abnormalities in a premorbidly occurring process. In contrast, the findings raise the hypothesis that cortical thickness reductions seen in past studies of individuals with more established BD may be more attributable to post-onset factors.

Funding

Novel therapies, risk pathways and prevention of mood disorders

National Health and Medical Research Council

Find out more...

CHARACTERISING FACIAL EMOTION PROCESSING NETWORKS IN BIPOLAR DISORDER

National Health and Medical Research Council

Find out more...

Neurobiological â riskâ and â resilienceâ biomarkers of severe mental illness

National Health and Medical Research Council

Find out more...

Enhancing and integrating addiction neuroscience knowledge with clinical practice, by transforming the approach to assessment and classification protocols, and improving outcomes by using neurocognitive phenotypes for tailored treatments

National Health and Medical Research Council

Find out more...

Research fellowship

National Health and Medical Research Council

Find out more...

History

Related Materials

  1. 1.
    DOI - Is published in 10.1016/j.pnpbp.2022.110687
  2. 2.
    ISSN - Is published in 02785846

Journal

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volume

122

Number

110687

Start page

1

End page

9

Total pages

9

Publisher

Elsevier Inc.

Place published

United States

Language

English

Copyright

© 2022 Elsevier Inc. All rights reserved.

Former Identifier

2006126338

Esploro creation date

2023-11-11

Usage metrics

    Scholarly Works

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC